Connie Montgomery: Every Patient Deserves Representation in Clinical Research
Connie Montgomery, National Member Board of Trustees Camden Coalition at Camden Coalition, shared American Society of Hematology‘s a post on LinkedIn:
“Trialport supports that all people need to be represented in clinical trials especially for those of us living with bleeding disorders and other diseases.”
American Society of Hematology shared a post on LinkedIn:
“Representation in clinical trials doesn’t improve by accident—it improves by design.
The ASH Toolkit for Clinical Trial Sponsors provides a step-by-step, practical resource to build equity into the trial life cycle from the outset.
Find concrete recommendations, examples, and curated references to help enhance access, broaden participation, and generate results that truly reflect the patients impacted by the disease or therapy.
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome